Chad Rusthoven, MD

Associate Clinical Professor, Radiation Oncology


FacultyPhoto
Medical School
  • MD, University of South Florida College of Medicine (2010)
Undergraduate School
  • BS, University of Florida (FL) (2005)
Internship
  • Washington Hospital Center/Georgetown University Program (2011)
Residency
  • University of Colorado, Chief Resident, Radiation Oncology (2015)
Languages
English
Department
Radiation Oncology

Professional Titles

  • Associate Professor of Radiation Oncology

Recognitions

  • Dr. Charles A. Coltman, Jr., Fellowship Award, The Hope Foundation for Cancer Research (2020)
  • Faculty inductee to the Gold Humanism Honor Society in recognition compassionate patient care, Gold Humanism Honor Society (2018)
  • American Brachytherapy Society Clinical Fellowship Award, American Brachytherapy Society (ABS) (2014)
  • Outstanding performance in medical internship, letter of commendation, Georgetown University/Washington Hospital Center (2011)
  • Merck Academic Excellence Award, University of South Florida College of Medicine (2010)
  • Alpha Omega Alpha (AOA), Alpha Omega Alpha Honor Medical Society (2009)
  • Phi Beta Kappa Honor Society, University of Florida (2005)
  • National Merit Scholar, National Merit Scholarship Corporation (2000)

Publications

  • Pike LRG, Miao E, Boe LA, Patil T, Imber BS, Myall NJ, Pollom EL, Hui C, Qu V, Langston J, Chiang V, Grant M, Goldberg SB, Palmer JD, Prasad RN, Wang TJC, Lee A, Shu CA, Chen LN, Thomas NJ, Braunstein SE, Kavanagh BD, Camidge DR, Rusthoven CG. Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC). J Clin Oncol. 2024 Jul 24;:JCO2302668. [Epub ahead of print] PubMed PMID: 39047224
  • Forghani F, Castillo R, Castillo E, PhD BJ, Rusthoven C, Kwak J, Moiseenko V, Grills I, Miften M, Vinogradskiy Y, Guerrero T. Is individual perfusion dose-response different than ventilation dose-response for lung cancer patients treated with radiotherapy?. Br J Radiol. 2023 Mar;96(1143):20220119. PubMed PMID: 36633096
  • Kowalchuk RO, Niranjan A, Hess J, Antonios JP, Zhang MY, Braunstein S, Ross RB, Pikis S, Deibert CP, Lee CC, Yang HC, Langlois AM, Mathieu D, Peker S, Samanci Y, Rusthoven CG, Chiang V, Wei Z, Lunsford LD, Trifiletti DM, Sheehan JP. Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer. J Neurosurg. 2023 Jun 1;138(6):1608-1614. PubMed PMID: 36433878
  • Wu TC, Stube A, Felix C, Oseguera D, Romero T, Goldman J, Garon EB, Lee JM, Glaspy J, Lisberg AE, Rusthoven CG, Camidge DR, Siva S, Solomon B, Lee A, Tenn SE, Shaverdian N, Steinberg ML, Raldow AC, Lee P. Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):118-122. PubMed PMID: 37023987
  • Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Mathieu D, Trudel C, Deibert CP, Malouff TD, Ruiz-Garcia H, Peterson JL, Patel S, Bonney P, Hwang L, Yu C, Zada G, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Fakhoury KR, Rusthoven CG, Dickstein DR, Sheehan JP, Trifiletti DM, Ahluwalia MS. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. J Neurooncol. 2023 Oct;165(1):63-77. PubMed PMID: 37889444

Practice Locations

Center Affiliations

Specialty Information

Specialties
  • Radiation Oncology, Board Certification
Conditions & Treatments
  • Cancers
  • Cancers - Lung Cancer
  • Cancers - Brain Cancer
Clinical Interests
Thoracic Oncology, Central Nervous System (CNS) Oncology, Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT)

Care Philosophy
Caring for patients with cancer is an incredible privilege. My goal is to provide state-of-the-art treatment and compassionate care for patients and their families.